Andrew R. Adams
Mairs & Power Growth Fund
Mairs & Power Growth Fund Zimmer Biomet Holdings Inc stake
total: 96
Mairs & Power Growth Fund ZBH trades
- Total transactions:
- 8
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 5
- Held since:
- 2019 Q3
- Held for:
- 7 quarters
- Latest activity:
- 2021 Q2
According to 2026 Q2 report, Mairs & Power Growth Fund doesn't hold any Zimmer Biomet Holdings Inc (ZBH) shares. To date, the estimated cost basis is nearly $135.22 for "buy" trades and estimated average "sell" price is $152.58. Mairs & Power Growth Fund first purchased ZBH in 2019 Q3, initially acquiring 640,000 shares. Since the initial investment in Zimmer Biomet Holdings Inc (ZBH), Mairs & Power Growth Fund has made 7 more transactions.
When did Mairs & Power Growth Fund sell Zimmer Biomet Holdings Inc (ZBH)?
Mairs & Power Growth Fund sold off the entire Zimmer Biomet Holdings Inc (ZBH) position in 2021 Q2.
When did Mairs & Power Growth Fund buy Zimmer Biomet Holdings Inc (ZBH)?
Mairs & Power Growth Fund first invested in Zimmer Biomet Holdings Inc (ZBH) in 2019 Q3 at the reported quarter-end price of $137.27 per share.
What's the cost basis of Mairs & Power Growth Fund's ZBH stake?
The estimated cost basis for Zimmer Biomet Holdings Inc (ZBH) stake is around $135.22 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $135.22
- Weighted AVG sell price:
- $152.58
Mairs & Power Growth Fund's historical trades in Zimmer Biomet Holdings Inc
8 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q2
|
0.00%
|
0
|
$160.08
|
|
-100% (-75,000)
|
-0.23%
|
|
2021 Q1
|
0.23%
|
75,000
|
$160.08
|
$12,006,000
|
-69.39% (-170,000)
|
-0.56%
|
|
2020 Q4
|
0.78%
|
$154.09
|
-54.50% (-293,500)
|
|||
|
2020 Q3
|
1.67%
|
$136.14
|
-16.32% (-105,000)
|
|||
|
2020 Q2
|
1.84%
|
$119.36
|
-2.28% (-15,000)
|
|||
|
2020 Q1
|
1.83%
|
$101.08
|
+6.21% (+38,500)
|
|||
|
2019 Q4
|
2.01%
|
$149.68
|
-3.12% (-20,000)
|
|||
|
2019 Q3
|
2.01%
|
$137.27
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.